2018
DOI: 10.1016/j.prp.2018.03.028
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
35
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 39 publications
(35 citation statements)
references
References 45 publications
0
35
0
Order By: Relevance
“…The previous works have identified multiplies miR-136-5p targets including UGT1A7, ADH7, and ROCK1 in cancers. 17,18 Next, we found CBX4 as a target for miR-136-5p. CBX4 belongs to the Polycomb group (PcG) family and revealed to promote lung cancer proliferation and metastasis through recruiting BMI-1, indicating CBX4 may be a possible therapeutic target in cancer.…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…The previous works have identified multiplies miR-136-5p targets including UGT1A7, ADH7, and ROCK1 in cancers. 17,18 Next, we found CBX4 as a target for miR-136-5p. CBX4 belongs to the Polycomb group (PcG) family and revealed to promote lung cancer proliferation and metastasis through recruiting BMI-1, indicating CBX4 may be a possible therapeutic target in cancer.…”
Section: Discussionmentioning
confidence: 86%
“…16 In addition, miR-136-5p was found decreased expression in lung squamous cell cancer and it may interact with UGT1A7 and ADH7 to regulate cellular metabolism processes. 17 We validated the direct connection of FOXP4-AS1 and miR-136-5p using luciferase activity reporter assay. The previous works have identified multiplies miR-136-5p targets including UGT1A7, ADH7, and ROCK1 in cancers.…”
Section: Discussionmentioning
confidence: 97%
“…Yan et al (2016) have shown miR‐136 inhibits the malignant process via RASAL2 in triple‐negative breast cancer. Xie et al (2018) recently demonstrated that miR‐136‐5p expression is downregulated in LUSC tissues. In our study, miR‐136‐5p also had a suppressive role on LUSC, which is consistent with existing research.…”
Section: Discussionmentioning
confidence: 99%
“…Samples from patients who had received radiotherapy or chemotherapy prior to their surgery were excluded from the present study. To study the expression of GLTSCR1 at the mRNA level and complete a survival analysis, clinicopathological features from TCGA database, a freely opened public platform, is a source for abundant cancer-related data (19), including 499 prostate cancer tissues and 52 normal prostate tissues, were also gathered. These features are summarized in Table I.…”
Section: Methodsmentioning
confidence: 99%